With locations in Israel and Germany, InspireMD is a medical device company that focuses on the development and commercialization of its proprietary stent technology MGuard. Today, InspireMD announced they have named Sol J. Barer, Ph.D to their Board of Directors.
The addition of Barer adds a great deal of credibility to the up-and-coming company. Dr. Barer is a respected name in the sector whom brings over 30 years of experience with biotechnology companies and is the founder and former Chairman, COO and CEO of Celgene, a NASDAQ-listed company.
One of the earliest moments of Dr. Barer’s career that led him to success occurred in 1980 when he was with the Celanese Research Company and he formed the biotechnology group that was subsequently spun out to form Celgene. Celegene’s market capitalization at his retirement was approximately $27 billion.
Dr. Barer holds a Ph.D in organic chemistry from Rutgers University and a bachelor’s degree from Brooklyn College. Currently, Dr. Barer is a Director of Amicus Therapeutics, Inc., Aegerion Pharmaceuticals, Inc. and ContraFect Corp. and serves as a senior advisor to a number of other biotechnology companies. Dr. Barer also serves as Chairman of the Board of Trustees of the Biotechnology Council of New Jersey and is on the Board of Trustees of Rutgers University, the Brooklyn CollegeFoundation and the Tourette Syndrome Association. Dr. Barer was previously the Commissioner of the New JerseyCommission on Science and Technology.
Leading the way at InspireMD is Asher Holzer whom is the co-founder and President of the company. Holzer commented, “It is an honor to add such an accomplished and recognized biotechnology leader like Sol Barerto our Board of Directors. I am confident we will benefit from Dr. Barer’s experience, expertise and industry relationships as we pursue FDA approval and build a first-rate sales and marketing organization. Dr. Barer’s years of developing and securing regulatory approval for life-saving and transformational products, coupled with his proven management and business expertise, will be invaluable assets for InspireMD.”
Currently, InspireMD is trading in the $2.59 range. To learn more about the company as a whole, visit the corporate website at: www.inspire-md.com